Alkeon Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.3M | Buy |
1,017,700
+200,000
| +24% | +$12.6M | 0.11% | 50 |
|
|
2025
Q1 | $43.3M | Sell |
817,700
-350,000
| -30% | -$18.5M | 0.09% | 62 |
|
|
2024
Q4 | $65.4M | Hold |
1,167,700
| – | – | 0.13% | 47 |
|
|
2024
Q3 | $61.2M | Buy |
1,167,700
+167,700
| +17% | +$8.79M | 0.1% | 51 |
|
|
2024
Q2 | $41.1M | Buy |
+1,000,000
| New | +$41.1M | 0.07% | 61 |
|
|
2023
Q4 | – | Sell |
-1,725,167
| Closed | -$39.5M | – | 88 |
|
|
2023
Q3 | $39.5M | Hold |
1,725,167
| – | – | 0.07% | 62 |
|
|
2023
Q2 | $28.4M | Sell |
1,725,167
-290,799
| -14% | -$4.8M | 0.05% | 68 |
|
|
2023
Q1 | $36M | Sell |
2,015,966
-222,296
| -10% | -$3.97M | 0.08% | 63 |
|
|
2022
Q4 | $65.2M | Buy |
2,238,262
+533,262
| +31% | +$15.5M | 0.25% | 53 |
|
|
2022
Q3 | $41.8M | Buy |
1,705,000
+205,000
| +14% | +$5.02M | 0.14% | 72 |
|
|
2022
Q2 | $6.23M | Buy |
+1,500,000
| New | +$6.23M | 0.02% | 101 |
|
|
2018
Q1 | – | Sell |
-25,000
| Closed | -$727K | – | 109 |
|
|
2017
Q4 | $727K | Buy |
+25,000
| New | +$727K | ﹤0.01% | 60 |
|